GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProText Mobility Inc (OTCPK:TXTM) » Definitions » EV-to-FCF

ProText Mobility (ProText Mobility) EV-to-FCF : -12.45 (As of Jun. 07, 2024)


View and export this data going back to 2003. Start your Free Trial

What is ProText Mobility EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, ProText Mobility's Enterprise Value is $8.79 Mil. ProText Mobility's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2014 was $-0.71 Mil. Therefore, ProText Mobility's EV-to-FCF for today is -12.45.

The historical rank and industry rank for ProText Mobility's EV-to-FCF or its related term are showing as below:

TXTM's EV-to-FCF is not ranked *
in the Biotechnology industry.
Industry Median: 8.325
* Ranked among companies with meaningful EV-to-FCF only.

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-07), ProText Mobility's stock price is $0.00094. ProText Mobility's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2014 was $-0.537. Therefore, ProText Mobility's PE Ratio for today is At Loss.


ProText Mobility EV-to-FCF Historical Data

The historical data trend for ProText Mobility's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProText Mobility EV-to-FCF Chart

ProText Mobility Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.88 -0.46 -1.05 -3.06 -4.57

ProText Mobility Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of ProText Mobility's EV-to-FCF

For the Biotechnology subindustry, ProText Mobility's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ProText Mobility's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ProText Mobility's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where ProText Mobility's EV-to-FCF falls into.



ProText Mobility EV-to-FCF Calculation

ProText Mobility's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=8.791/-0.706
=-12.45

ProText Mobility's current Enterprise Value is $8.79 Mil.
ProText Mobility's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.71 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ProText Mobility  (OTCPK:TXTM) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

ProText Mobility's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.00094/-0.537
=At Loss

ProText Mobility's share price for today is $0.00094.
ProText Mobility's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.537.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


ProText Mobility EV-to-FCF Related Terms

Thank you for viewing the detailed overview of ProText Mobility's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


ProText Mobility (ProText Mobility) Business Description

Traded in Other Exchanges
N/A
Address
One West Las Olas Boulevard, Suite 500, Fort Lauderdale, FL, USA, 33301
ProText Mobility Inc is a Biotech Company developing a Hemp/CBD - Cannabis medicines platform for the legal cannabis industry, using proprietary live plant extraction processes & technologies. Protext has engaged in the research, testing, and development of bioavailable botanical products all-natural ingredients formulated for nutraceuticals and pharmaceutical applications through proprietary live plant extraction technology.
Executives
Peter Sealey director 37400 CENTRAL COURT, NEWARK CA 94560

ProText Mobility (ProText Mobility) Headlines

From GuruFocus